Akumin (Akumin) Days Payable : 29.05 (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Akumin Days Payable?

Akumin's average Accounts Payable for the three months ended in Sep. 2023 was $50.3 Mil. Akumin's Cost of Goods Sold for the three months ended in Sep. 2023 was $158.0 Mil. Hence, Akumin's Days Payable for the three months ended in Sep. 2023 was 29.05.

The historical rank and industry rank for Akumin's Days Payable or its related term are showing as below:

AKUMQ' s Days Payable Range Over the Past 10 Years
Min: 21.28 Med: 34.1 Max: 55.33
Current: 22.5

During the past 8 years, Akumin's highest Days Payable was 55.33. The lowest was 21.28. And the median was 34.10.

AKUMQ's Days Payable is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 68.78 vs AKUMQ: 22.50

Akumin's Days Payable increased from Sep. 2022 (18.55) to Sep. 2023 (29.05). It may suggest that Akumin delayed paying its suppliers.

Akumin Days Payable Historical Data

The historical data trend for Akumin's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Days Payable Chart

Akumin Annual Data

Trend

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

45.15

34.55

33.65

25.88

21.28

Akumin Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															18.55	20.15	18.21	19.87	29.05

Competitive Comparison of Akumin's Days Payable

For the Diagnostics & Research subindustry, Akumin's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akumin's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Days Payable distribution charts can be found below:

* The bar in red indicates where Akumin's Days Payable falls into.

Akumin Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Akumin's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (34.326	+	36.618)	/	2 )	/	608.377	*	365
=	35.472					/	608.377	*	365
=	21.28

Akumin's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (43.575	+	57.061)	/	2 )	/	158.047	*	365 / 4
=	50.318					/	158.047	*	365 / 4
=	29.05

Akumin Days Payable Related Terms

Thank you for viewing the detailed overview of Akumin's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (Akumin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AKU:Canada

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Ronald J. Bienias	officer: Chief Restructuring Officer	C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar	officer: See remarks	C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer	officer: See Remarks	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp	10 percent owner	3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner	10 percent owner	3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis	officer: Chief Information Officer	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron	officer: See Remarks	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322